Clinical Rheumatology

, Volume 28, Issue 7, pp 749–756 | Cite as

Systemic effects of intra-articular corticosteroids

  • George S. HabibEmail author
Review Article


The objective of this study was to review all the published articles in the English literature about the systemic effects of intra-articular corticosteroid injection (IACI) in humans. Reports were searched through Pubmed using the terms intraarticular or intra-articular and steroids, corticosteroids, or glucocorticosteroids up and including the year 2007. Reports were also located through references of articles. Only objective findings outside the injected joint were included. The overwhelming majority of the studies was done at the knee joint and in rheumatoid arthritis/juvenile idiopathic arthritis patients. Many of the studies were done on the hypothalamic–pituitary–adrenal axis. Serum cortisol decreased within hours with a nadir after usually 24–48 h following the IACI. Recovery to baseline takes 1–4 weeks and sometimes longer depending on the type and dose of IACI and on the number of injected joints. Serum cortisol levels were blunted following adrenocorticotropic hormone stimulation in a small proportion of patients following methylprednisolone acetate injection and more common following other preparations. IACI resulted in a transient increase in blood glucose levels over few days in controlled diabetic patients with knee osteoarthritis. Peak levels are around 300 mg%. IACIs are associated with reduction in inflammatory markers like C-reactive protein and erythrocyte sedimentation rate that start few days following the IACI and could last for months. The effect on inflammatory cytokines is immediate with significant decrease within hours. IACI may induce remission also in patients with oligo-/polyarthritis and/or in patients with extra-articular manifestations. Other metabolic, hematologic, vascular, allergic, visual, psychologic, and other effects were also reported.


Corticosteroids Intra-articular Systemic effects 





  1. 1.
    Snippe JC, Gambardella RA (2005) Use for injections in osteoarthritis in joints and sports activity. Clin Sports Med 24:83–91CrossRefGoogle Scholar
  2. 2.
    Caldwell JR (1996) Intra-articular corticosteroids. Guide for selection and indications for use. Drugs 52:S07–S14CrossRefGoogle Scholar
  3. 3.
    Hollander JL, Brown EM, Jessar RA, Brown CY (1951) Hydrocortisone and cortisone injected into arthritis joints: comparative effects and use of hydrocortisone as a local antiarthritic agent. JAMA 147:16329–16335Google Scholar
  4. 4.
    Schwartz S (1960) Intra-articular administration of triamcinolone acetonide: a preliminary report. N Y State J Med 60:3422–3425PubMedGoogle Scholar
  5. 5.
    Kendall PH (1967) Triamcinolone hexacetonide. A new corticosteroid for intra-articular therapy. Ann Phys Med 9:55–58PubMedGoogle Scholar
  6. 6.
    Norcross BM, Winter JA (1961) Methylprednisolone acetate: a single preparation suitable for both intra-articular and systemic use. N Y State J Med 61:552–561PubMedGoogle Scholar
  7. 7.
    Roberts HJ (1965) Local injection of a preparation containing two betamethasone esters in the treatment of noninfectious musculoskeletal disorders. J Am Geriatr Soc 13:275–291PubMedGoogle Scholar
  8. 8.
    Centeno LM, Moore ME (1994) Preferred intraarticular corticosteroids and associated practice; a survey of members of the American college of rheumatology. Arthritis Care Res 7:151–155PubMedCrossRefGoogle Scholar
  9. 9.
    Zulian F, Martini G, Gobber D, Plebani M, Zacchello F, Manners P (2004) Triamcinolone acetanoide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-bind trial. Rheumatology (Oxford) 43:1288–1291CrossRefGoogle Scholar
  10. 10.
    Armstrong RD, English J, Gibsn T, Chakraborty J, Marks V (1981) Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 40:571–574PubMedCrossRefGoogle Scholar
  11. 11.
    Bertouch JV, Sallustio BC, Mefflin BJ, Brooks BM (1983) A comparison of plasma methylprednisolone concentrations following intraarticular injection in patients with rheumatoid arthritis and osteoarthritis. Aust N Z Med 13:583–585Google Scholar
  12. 12.
    Gless KH, Klee HR, Vecsei P, Weber M, Haack D, Lichtwakd K (1981) Plasma concentration and systemic effect of betamethazone following intraarticular injection. Disch Med Wschr 106:704–707Google Scholar
  13. 13.
    Weitof T, Ronnblom L (2006) Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients. Ann Rheum Dis 65:955–957CrossRefGoogle Scholar
  14. 14.
    Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G (1986) Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 39:313–317PubMedGoogle Scholar
  15. 15.
    Derendorf H, Mollman H, Voortman G, van den Ouweland FA, van de Putte LB, Gevers G et al (1990) Pharmacokinetics of rimexolone after intra-articular administration. J Clin Pharmacol 30:476–479PubMedGoogle Scholar
  16. 16.
    Blyth T, Hunter JA, Stirling A (1994) Pain relief in the rheumatoid knee after steroid injection: a single blind comparison of hydrocortisone succinate, and triamcinolone acetonide or heaxacetonide. Br J Rheumatol 3:461–463CrossRefGoogle Scholar
  17. 17.
    Lazarevic MB, Skosey JL, Djordjevic-Denic G, Swedler WI, Zgardic I, Myones BA (1995) Reduction of cortisol levels after single intra-articular and intramuscular steroid injection. Am J Med 99:370–373PubMedCrossRefGoogle Scholar
  18. 18.
    Mader R, Lavi L, Luboshitzky R (2005) Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolonone. Arthritis Rheumatism 52:924–928PubMedCrossRefGoogle Scholar
  19. 19.
    Younes M, Neffati F, Touzi M, Hassan-Zrour S, Fendri Y, Bejia I et al (2007) Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine 74:472–476PubMedCrossRefGoogle Scholar
  20. 20.
    Furtado RN, Oliveira LM, Natour J (2005) Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study. J Rheumatol 32:1691–1698PubMedGoogle Scholar
  21. 21.
    Schweitzer DH, Le-Brun PP, Krishnaswami S, Derendorf H (2000) Clinical and pharmacological aspects of accidental triamcinolone acetonide overdose; a case study. Neth J Med 56:12–16PubMedGoogle Scholar
  22. 22.
    Huppertz HI, Pfuller H (1997) Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children. J Rheumatol 24:1833–1837PubMedGoogle Scholar
  23. 23.
    Emkey RD, Lindsay R, Lyssy J, Weisberg JS, Dempster DW, Shen V (1996) The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 39:277–282PubMedCrossRefGoogle Scholar
  24. 24.
    Lzarevic MB, Skosey JL, Djordjevic-Denic G, Swedler WI, Zgradic I, Myones BL (1995) Reduction of cortisl levels after single intra-articular and intramuscular steroid injection. Am J Med 99:370–373CrossRefGoogle Scholar
  25. 25.
    Steer JH, Ma DT, Dusci L, Garas G, Pedersen KE, Joyce DA (1998) Altered leukocyte trafficking and suppressed tumor necrosis factor alpha release from peripheral blood monocytes after intra-articular glococorticoid treatment. Ann Rheum Dis 57:732–737PubMedCrossRefGoogle Scholar
  26. 26.
    Duclos M, Guinot M, Colsy M, Merle F, Baudot C, Corcuff JB et al (2007) High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc 39:1036–1043PubMedCrossRefGoogle Scholar
  27. 27.
    O’Sullivan MM, Rumfeld WR, Jones MK, Williams BD (1985) Cushing’s syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections. Ann Rheum Dis 44:561–563PubMedCrossRefGoogle Scholar
  28. 28.
    Reid DM, Eastmond C, Rennie JAN (1986) Hypothalamic-pituitary-adrenal axis suppression after repeated intra-articular steroid injection. Ann Rheum Dis 45:87PubMedCrossRefGoogle Scholar
  29. 29.
    Esselinckx W, Bacon PA, Ring EFJ, Crooke D, Collins AJ, Demottaz D (1978) A thermographic assessment of three intra-aricular prednisolone analogues given in rheumatoid synovitis. Br J Clin Pharmac 5:447–451Google Scholar
  30. 30.
    Weiss S, Fischel B, Kisch ES (1980) Systemic effect of intra-articular steroid preparations. Ann Rheum Dis 39:413–414PubMedCrossRefGoogle Scholar
  31. 31.
    Gondwe JS, Davidson JE, Deeey S, Sills J, Cleary AG (2005) Secondary Cushing’s syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration. Rheumatology (Oxford) 44:1457–1458CrossRefGoogle Scholar
  32. 32.
    Kumar S, Singh RJ, Reed AM, Lteif AN (2004) Cushing’s syndrome after intra-articular and intradermal administration of triamcinolone acetanoiode in three pediatric patients. Pediatrics 113:1820–1824PubMedCrossRefGoogle Scholar
  33. 33.
    Bloom BJ, Miller LC, Tucker LB, Alario AJ, Schaller JG (1997) Intra-articular corticosteroids in juvenile chronic arthritis. Arthritis Rheum 39:S46Google Scholar
  34. 34.
    Black DM, Filak AT (1989) Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection. J Fam Pract 28:462–463PubMedGoogle Scholar
  35. 35.
    Habib G, Anu-Ahmad R (2007) Lack of effect of corticosteroid injection at the shoulder joint on blood glucose levels in diabetic patients. Clin Rheum 26:566–568CrossRefGoogle Scholar
  36. 36.
    Habib G, Bashir M, Jabbour A (2008) Increased blood glucose levels following intra-articular injection of methylprednisolone acetate in controlled diabetic patients with symptomatic osteoarthritis of the knee. ARD 67:1790–1791PubMedGoogle Scholar
  37. 37.
    Habib GS, Safia A (2009) The effect of intra-articular steroid injection of betamethasone acetate/betamethasone sodium phosphate on blood glucose levels in controlled diabetic patients with symptomatic osteoarthritis of the knee. Clin Rheum 28:85–87CrossRefGoogle Scholar
  38. 38.
    Weitoft T, Larsson A, Saxne T, Ronnblom L (2005) Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Ann Rheum Dis 64:1750–1753PubMedCrossRefGoogle Scholar
  39. 39.
    Heuck C, Wolthers OD, Herlin T (1999) Growth-suppressive effect of intra-articular glucocorticoids detected by knemometry. Horm Res 52:95–96PubMedCrossRefGoogle Scholar
  40. 40.
    Taylor HJ, Fowler PD, David MJ, Dawes PT (1991) Intra-articular steroid: cofounder of clinical trials. Clin Rheumatol 10:38–42PubMedCrossRefGoogle Scholar
  41. 41.
    Pitsillides AA, Will RK, Bayliss MT, Edwards JCW (1994) Circulating and synovial fluid hyaluronan levels. Arthritis Rheum 37:1030–1038PubMedCrossRefGoogle Scholar
  42. 42.
    Alex P, Szodoray P, Arthur E, Willis L, Hynd R, Flinn D et al (2007) Influence of intraarticular corticosteroid administration on serum cytokines in rheumatoid arthritis. Clin Rheumatol 26:845–848PubMedCrossRefGoogle Scholar
  43. 43.
    Gladman DD, Bombardier C (1987) Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis. Arthritis Rheum 30:1065–1068PubMedCrossRefGoogle Scholar
  44. 44.
    Pattrick M, Doherty M (1987) Facial flushing after intra-articular injection of steroid. Br Med J (Clin Res Ed) 295:1380CrossRefGoogle Scholar
  45. 45.
    Koehler BA, Urowitz MB, Killinger DW (1974) The systemic effects of intra-articular corticosteroids. J Rheum 1:117–125PubMedGoogle Scholar
  46. 46.
    Magni Manzoni S, Viola S, Beduschi L, Martini A, Ravelli A (2002) Transient remission of systemic manifestations following intraarticular triamcinolone hexacetanoide injection in a boy with systemic juvenile idiopathic arthritis. Clin Exp Rheumatol 20:735PubMedGoogle Scholar
  47. 47.
    Huppertz HI, Tschammler A, Horwitz AE, Schwab KO (1995) Intra-articular corticosteroids for chronic arthritis in children. Efficacy and effect on cartilage and growth. J Pediatr 127:317–321PubMedCrossRefGoogle Scholar
  48. 48.
    Karsh J, Yang WH (2003) An anaphylactic reaction to intra-articular triamcinolone: a case report and review of the literature. Ann Allergy Asthma Immunol 90:254–258PubMedCrossRefGoogle Scholar
  49. 49.
    Mace S, Vadas P, Pruzanski W (1997) Anaphylactic shock induced by intraarticular injection of methylprednisolone acetate. J Rheumatol 24:1191–1194PubMedGoogle Scholar
  50. 50.
    Larsson G (1989) Anaphylactis shock after i.a. administration of triamcinolone acetonide in a 35-year-old female. Scand J Rheumatol 18:441–442PubMedCrossRefGoogle Scholar
  51. 51.
    Mondal LK, Sarkar K, Datta H, Chatterjee PR (2005) Acute bilateral central serous chorioretinopathy following intra-articuar injection of corticosteroid. Indian J Ophthalmol 53:132–134PubMedCrossRefGoogle Scholar
  52. 52.
    Baloch N (1974) Steroid psychosis: a case report. Br J Psychiatry 124:545–546PubMedCrossRefGoogle Scholar
  53. 53.
    Robinson DE, Harrison-Hansley E, Spencer RF (2000) Steroid psychosis after an intra-articular injection. Ann Rheum Dis 59:927PubMedCrossRefGoogle Scholar
  54. 54.
    Courtman NH, Weighill FJ (1992) Systemic tuberculosis in association with intra-articular steroid therapy. J R Coll Surg Edinb 37:425PubMedGoogle Scholar
  55. 55.
    Gutierrez-Urena S, Ramus-Remus C (1999) Persistent hiccups associated with intraarticular corticosteroid injection. J Rheum 26:760PubMedGoogle Scholar
  56. 56.
    Edelman J, Potter JM, Hacket LP (1986) The effect of intraarticular steroids on plasma salicylate concentrations. Br J Clin Pharmacol 21:301–307PubMedGoogle Scholar

Copyright information

© Clinical Rheumatology 2009

Authors and Affiliations

  1. 1.Department of MedicineCarmel Medical CenterHaifaIsrael
  2. 2.Faculty of MedicineTechnion, Israel Institute of TechnologyHaifaIsrael
  3. 3.Rheumatology ClinicNazareth HospitalNazarethIsrael

Personalised recommendations